NEOGENOMICS INC (NEO) › Shareholders' EquityNEOGENOMICS INC (NEO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: $5.64M2010: $3.13M2011: $5.90M2012: $9.22M2013: $21.71M2014: $60.41M2015: $208.52M2016: $162.32M2017: $171.96M2018: $320.44M2019: $507.41M2020: $694.29M2021: $1.11B2022: $998.02M2023: $941.54M2024: $902.34M2025: $836.56M$836.56M2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$836.56M-7.3%2024$902.34M-4.2%2023$941.54M-5.7%2022$998.02M-9.9%2021$1.11B+59.6%2020$694.29M+36.8%2019$507.41M+58.3%2018$320.44M+86.3%2017$171.96M+5.9%2016$162.32M-22.2%2015$208.52M+245.2%2014$60.41M+178.2%2013$21.71M+135.6%2012$9.22M+56.3%2011$5.90M+88.1%2010$3.13M-44.4%2009$5.64M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share